1. Home
  2. WLDS vs IMNN Comparison

WLDS vs IMNN Comparison

Compare WLDS & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wearable Devices Ltd.

WLDS

Wearable Devices Ltd.

BUY

Current Price

$1.39

Market Cap

7.7M

ML Signal

BUY

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$1.25

Market Cap

7.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDS
IMNN
Founded
2014
1982
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
7.9M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
WLDS
IMNN
Price
$1.39
$1.25
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $17.00
AVG Volume (30 Days)
★ 201.0K
98.7K
Earning Date
08-24-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.96
52 Week High
$6.50
$4.93

Technical Indicators

Market Signals
Indicator
WLDS
IMNN
Relative Strength Index (RSI) 44.82 50.77
Support Level $1.30 $0.96
Resistance Level $1.51 $1.59
Average True Range (ATR) 0.10 0.09
MACD 0.03 0.02
Stochastic Oscillator 69.44 73.61

Price Performance

Historical Comparison
WLDS
IMNN

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

Share on Social Networks: